Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
- pharma
Carbomer homopolymer type a (allyl pentaerythritol crosslinked)
CAS 138757-68-3
Concern score
Not assessed — no hazard data yet.
Why it's flagged
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 32 mg
Regulation
No restrictions found. Carbomer homopolymer type a (allyl pentaerythritol crosslinked) appears in these published regulatory listings.
- definition_level:incomplete
- definition_type:primary
- inactive_ingredient_database
- ingredient_type:ingredient substance
- substance_class:polymer
- substance_type:polymer
USFDAinactive ingredient database5 entries — 2 administration routes
- Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 32 mgSource →
- Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 80 mgSource →
- Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 525 mgSource →
- Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 8 mgSource →
- Route: TOPICAL; Dosage form: LOTION; Maximum daily exposure: 43 mgSource →
USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as polymer.
- openFDA substance registry classifies this ingredient as polymer.Source →
Evidence
No graded sources yet for Carbomer homopolymer type a (allyl pentaerythritol crosslinked). We publish evidence only once a source is linked and reviewed — this ingredient is in the catalog, but has not been assessed.
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Good fit
